Integrated Wealth Counsel’s GSK GSK Stock Holding History

Integrated Wealth Counsel’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$162K	Hold	3,363	–	–	0.35%	35
2016 Q3	$181K	Buy	3,363 +323	+11%	+$17.7K	0.38%	31
2016 Q2	$165K	Hold	3,040	–	–	0.38%	28
2016 Q1	$154K	Hold	3,040	–	–	0.35%	29
2015 Q4	$153K	Hold	3,040	–	–	0.24%	27
2015 Q3	$146K	Hold	3,040	–	–	0.24%	27
2015 Q2	$158K	Hold	3,040	–	–	0.22%	31
2015 Q1	$175K	Hold	3,040	–	–	0.22%	31
2014 Q4	$162K	Hold	3,040	–	–	0.19%	31
2014 Q3	$175K	Hold	3,040	–	–	0.18%	31
2014 Q2	$203K	Hold	3,040	–	–	0.16%	40
2014 Q1	$203K	Sell	3,040 -85	-3%	-$5.75K	0.16%	56
2013 Q4	$209K	Hold	3,125	–	–	0.15%	58
2013 Q3	$196K	Hold	3,125	–	–	0.14%	59
2013 Q2	$195K	Buy	+3,125	New	+$198K	0.14%	63

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Integrated Wealth Counsel's GSK Position: Q4 2016 in Review

Integrated Wealth Counsel held its GSK (GSK) position steady in Q4 2016 at 3,363 shares worth $162K. The position accounts for 0.35% of the portfolio, ranked #35.

Integrated Wealth Counsel first reported a position in GSK in Q2 2013 and has held it in 15 quarters since. The position peaked at $209K in Q4 2013. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

Integrated Wealth Counsel held 3,363 shares of GSK worth $162K as of Q4 2016.
Integrated Wealth Counsel left its GSK share count unchanged in Q4 2016.
GSK made up 0.35% of Integrated Wealth Counsel's portfolio in Q4 2016, its #35 holding.
Integrated Wealth Counsel first reported a position in GSK in Q2 2013 and has held it in 15 quarters since.
Integrated Wealth Counsel's GSK position peaked at $209K in Q4 2013.
762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Integrated Wealth Counsel's 13F filing for Q4 2016, filed 6 Feb 2017.